| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00002281-200105000-00003 |
| P698 | PubMed publication ID | 11333343 |
| P2093 | author name string | Taylor PC | |
| P433 | issue | 3 | |
| P304 | page(s) | 164-169 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Current Opinion in Rheumatology | Q15750473 |
| P1476 | title | Anti-tumor necrosis factor therapies | |
| P478 | volume | 13 |
| Q37445355 | A case of tuberculous arthritis following the use of etanercept |
| Q43161903 | AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression. |
| Q31089069 | Anakinra treatment of patients with rheumatoid arthritis |
| Q24673716 | Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety |
| Q44124071 | Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis |
| Q89791826 | Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides |
| Q35200049 | Clinical pharmacology of old age syndromes |
| Q36837890 | Cytokines and the early vein graft: strategies to enhance durability |
| Q34800330 | Double anti-angiogenic and anti-inflammatory protein Valpha targeting VEGF-A and TNF-alpha in retinopathy and psoriasis |
| Q28205951 | Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays |
| Q28505264 | Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) |
| Q34360546 | Immunotherapy for rheumatoid arthritis |
| Q43883722 | Infliximab chimaeric anti-tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes |
| Q36194610 | Infliximab chimeric antitumor necrosis factor-a monoclonal antibody as potential treatment for myelodysplastic syndromes. |
| Q44692619 | Infliximab-induced lupus in Crohn's disease: a case report. |
| Q33267344 | Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis |
| Q84744105 | Modulation of immune and inflammatory responses on experimental arthritis following intraarticular gene transfer of tumor necrosis factor receptor-immunoglobulin Fc |
| Q48132042 | Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis. |
| Q44290205 | NADPH oxidase priming and p47phox phosphorylation in neutrophils from synovial fluid of patients with rheumatoid arthritis and spondylarthropathy |
| Q44390003 | Novel effects of On-Chung-Eum, the traditional plant medicine, on cytokine production in human mononuclear cells from Behçet's |
| Q35040779 | Novel therapies for the treatment of inflammatory airway disease |
| Q37601987 | Ramsay hunt syndrome in a patient with rheumatoid arthritis after treatment with infliximab |
| Q52546388 | Requirement for TNF-Tnfrsf1 signalling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum. |
| Q42588233 | TNF-alpha and shear stress-induced large artery adaptations |
| Q35026157 | Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart. |
| Q31139165 | Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells |
| Q53983532 | Treatment of experimental autoimmune myasthenia gravis with recombinant human tumor necrosis factor receptor Fc protein. |
| Q45180236 | Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report |
| Q34185821 | Tumor necrosis factor signaling. |
| Q34731141 | VEGF and imaging of vessels in rheumatoid arthritis |
| Q79802311 | [Etanercept in rheumatoid arthritis patients with a poor therapeutic response to infliximab] |
Search more.